Verve Therapeutics

Eli Lilly

Biotech

Eli Lilly pays $1B upfront to buy gene editing partner Verve

Eli Lilly confirms its buyout of Verve after an M&A report by the Financial Times Monday.

James Waldron Jun 17, 2025 4:35am

Gene editing therapy patient KJ with Drs Ahrens-Nicklas and Musunuru

Boy with rare disease 'thriving' after 1st custom gene therapy

May 15, 2025 1:00pm

roadmap hurdles

Verve posts clean PCSK9 editor profile, teeing up Lilly decision

Apr 14, 2025 7:00am

u turn turnaround return

Vertex axes Verve gene editing pact amid shift in R&D priorities

Feb 27, 2025 9:05am

Graphic of someone in a boat navigating the rise and fall of different data riding data plots like a wave

Verve halts VERVE-101 enrollment, focuses on 2nd PCSK9 editor

Apr 2, 2024 7:00am

a 49ers fan lifts his fists in celebration during Sundays NFC Championship

Biotech insiders savor 49ers' latest victory in Super Bowl run

Jan 30, 2024 7:00am